- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02609256
Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery (SMART)
Stereotactic Infarct Tissue Aspiration (SITA) for Malignant Infarction of Middle Cerebral Artery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Malignant middle cerebral artery infarction (MMCI) has a fatality rate of up to 80%, due to massive brain edema, increased intracranial pressure, and cerebral herniation. The herniation-induced death usually occured during the first week, despite aggressive osmotherapy with mannitol or hypertonic saline, sedation, and eventually hyperventilation, buffers, or hypothermia. A growing evidence show that decompression craniectomy (DC) can produce a significant reduction in mortality rate and an improvement in neurological outcome, but the controversy of the DC still exists. There is an urgent need to find a more effective treatment method. Given that brain tissue necrosis-induced edema and cerebral herniation is the key reason of fatality and disability of MMCI patients, the investigators argue that the reduction of cerebral tissue volume by stereotactic infarct tissue aspiration (SITA) is likely to reach the decompression effect similar to the DC. Recently, the investigators performed SITA in 2 MMCI patients who were qualified for decompressive craniectomy, but refused by patient relatives, and their neurological function significantly improved.
The project is a prospective, randomized, single center, open label, clinical controlled trail. The eligible patients for enrollment are as follows: (1)ages from 40 to 90 years old; (2) malignant cerebral artery infarction within 48h onset; (3) craniotomy decompression can not be performed due to the contraindications, or refused by the patient or relatives. The patients are randomly assigned into 2 groups: (1) Medical therapy group: receiving osmotic therapy with mannitol and glycerol fructose,anti-platelet treatment, statins, and other symptomatic treatments such as controlling blood pressure, blood sugar, and infection, and tracheal intubation or incision, etc; (2) SITA group: receiving minimally invasive aspiration of infarct tissue 24-48 hours after stroke attacked on the basis of medical treatment. This study is aimed at comparing the efficacy and safety of of SITA in patients with MMCI.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Liaoning
-
Shenyang, Liaoning, China, 110840
- General Hospital of Shenyang Military Region
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ages from 40 to 90
- within 48 hours of onset
- brain imaging confirmed malignant middle cerebral artery infarction (DWI+MRA)
- infarction volume > 145ml
- craniotomy decompression can not be performed due to the contraindications, or refused by the patient or relatives
- signed informed consent.
Exclusion Criteria:
- hemorrhagic stroke
- severe infection or severe disfunction of liver, kidney, hematopoietic system, endocrine system and other serious diseases
- other clinical trials within 3 months
- a negative attitude towards SITA by patient or relatives
- other conditions not eligible for the trail judged by the researchers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stereotactic infarct tissue aspiration
Patients receive the stereotactic infarct tissue aspiration 24-48 hours after cerebral infarction beside medical therapy.
|
The patient posed supine position to expose local skin and puncture point was located at 6.5 cm behind the hairline of the lesion side, and 5.0 cm lateral of midline.
After routine skin preparation and disinfection, 5% lidocaine 2-5 ml was injected for local anesthesia.
The skin was cut to expose periosteum by a scalpel.
After skull was vertically drilled through with a 6mm diameter hole, a sterile tube with a needle in tube was put about 8 cm into centrum semiovale.
The needle was put out and about 50ml necrosis brain tissue was aspirated by a 20 ml syringe.
The tube was fixed into the skin about 2 cm after subcutaneous tunnel, and connected to the drainage bag.
Surgical area was sterilized and wrapped by sterile gauze bandage.
osmotic therapy with mannitol and glycerol fructose,anti-platelet treatment, statins, and other symptomatic treatments such as controlling blood pressure, blood sugar, and infection, and tracheal intubation or incision, etc
|
Sham Comparator: Medical therapy
osmotic therapy with mannitol and glycerol fructose,anti-platelet treatment, statins, and other symptomatic treatments such as controlling blood pressure, blood sugar, and infection, and tracheal intubation or incision, etc;
|
osmotic therapy with mannitol and glycerol fructose,anti-platelet treatment, statins, and other symptomatic treatments such as controlling blood pressure, blood sugar, and infection, and tracheal intubation or incision, etc
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Modified Rankin Scale(mRS) 0-3 vs mRS 4-6
Time Frame: 90±7days
|
90±7days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
National Institute of Health stroke scale(NIHSS)
Time Frame: 14±2days
|
NIHSS score improvement
|
14±2days
|
Mean survival time
Time Frame: 1 year
|
1 year
|
|
death due to any reasons
Time Frame: 90±7days
|
90±7days
|
|
mRS 0-4 compared with mRS 5 or 6
Time Frame: 90±7days
|
90±7days
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The number of Local hemorrhage cases
Time Frame: 14±2 days
|
14±2 days
|
The number of intracranial hemorrhage cases
Time Frame: 14±2 days
|
14±2 days
|
Major cardiovascular events
Time Frame: during the surgery
|
during the surgery
|
The number of intracranial infection cases
Time Frame: 14±2 days
|
14±2 days
|
The number of Local infection cases
Time Frame: 14±2 days
|
14±2 days
|
Collaborators and Investigators
Investigators
- Study Chair: Huisheng Chen Jing Qiu, PhD, Director
Publications and helpful links
General Publications
- van Middelaar T, Richard E, van der Worp HB, van den Munckhof P, Nieuwkerk PT, Visser MC, Stam J, Nederkoorn PJ. Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: A cohort study. BMC Neurol. 2015 Aug 28;15:156. doi: 10.1186/s12883-015-0407-0.
- Hofmeijer J, Amelink GJ, Algra A, van Gijn J, Macleod MR, Kappelle LJ, van der Worp HB; HAMLET investigators. Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space-occupying hemispheric infarction. Trials. 2006 Sep 11;7:29. doi: 10.1186/1745-6215-7-29.
- Neugebauer H, Heuschmann PU, Juttler E. DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols. BMC Neurol. 2012 Oct 2;12:115. doi: 10.1186/1471-2377-12-115.
- Raffiq MA, Haspani MS, Kandasamy R, Abdullah JM. Decompressive craniectomy for malignant middle cerebral artery infarction: Impact on mortality and functional outcome. Surg Neurol Int. 2014 Jun 26;5:102. doi: 10.4103/2152-7806.135342. eCollection 2014.
- Hatefi D, Hirshman B, Leys D, Lejeune JP, Marshall L, Carter BS, Kasper E, Chen CC. Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. Surg Neurol Int. 2014 May 15;5:72. doi: 10.4103/2152-7806.132589. eCollection 2014. No abstract available.
- Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touze E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007 Sep;38(9):2506-17. doi: 10.1161/STROKEAHA.107.485235. Epub 2007 Aug 9.
- Simard JM, Sahuquillo J, Sheth KN, Kahle KT, Walcott BP. Managing malignant cerebral infarction. Curr Treat Options Neurol. 2011 Apr;13(2):217-29. doi: 10.1007/s11940-010-0110-9.
- Juttler E, Unterberg A, Woitzik J, Bosel J, Amiri H, Sakowitz OW, Gondan M, Schiller P, Limprecht R, Luntz S, Schneider H, Pinzer T, Hobohm C, Meixensberger J, Hacke W; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014 Mar 20;370(12):1091-100. doi: 10.1056/NEJMoa1311367.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Ischemia
- Stroke
- Brain Infarction
- Cerebral Arterial Diseases
- Intracranial Arterial Diseases
- Cerebral Infarction
- Infarction
- Infarction, Middle Cerebral Artery
Other Study ID Numbers
- k(2015)32
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Middle Cerebral Artery Infarction
-
University of Roma La SapienzaNot yet recruitingMiddle Cerebral Artery Occlusion With Cerebral Infarction
-
Assistance Publique - Hôpitaux de ParisTerminatedMalignant Middle Cerebral Artery InfarctionFrance
-
National University of MalaysiaCytopeutics Sdn. Bhd.UnknownMiddle Cerebral Artery InfarctionMalaysia
-
University of MichiganCompletedStroke | Stroke, Chronic | Stroke, Middle Cerebral Artery With InfarctionUnited States
-
All India Institute of Medical Sciences, New DelhiPostgraduate Institute of Medical Education and Research; Sanjay Gandhi Postgraduate... and other collaboratorsCompletedMiddle Cerebral Artery Infarction | Anterior Cerebral Artery InfarctionIndia
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Middle Cerebral Artery With Infarction, Rehabilitation, Upper Limb Recovery, Economic BurdonIndia
-
Xuanwu Hospital, BeijingRecruitingInfarction, Middle Cerebral Artery | Symptomatic Chronic Middle Cerebral Artery OcclusionChina
-
UCB S.A. - Pharma SectorTerminatedAcute Ischaemic Middle Cerebral Artery StrokeSweden, Argentina, Austria, Belgium, France, Germany, Greece, Hungary, Italy, Norway, Poland, Singapore, Spain, Taiwan, Turkey
-
Ege UniversityCompletedCerebral HerniationTurkey
-
Celularity IncorporatedCelgene CorporationTerminatedStroke, Acute | Middle Cerebral Artery Stroke | Posterior Cerebral Artery StrokeUnited States
Clinical Trials on Stereotactic infarct tissue aspiration
-
Chinese PLA General HospitalThe First Affiliated Hospital of Nanchang University; First Affiliated Hospital... and other collaboratorsCompletedIntracranial Hemorrhage, HypertensiveChina
-
Stanford UniversityCompletedLymphoma | Hodgkin DiseaseUnited States
-
MedImmune LLCAstraZenecaCompletedArthritisUnited States
-
Johns Hopkins UniversityGenentech, Inc.Completed
-
Huazhong University of Science and TechnologyUnknownHypertensive Intracerebral HemorrhageChina
-
M.D. Anderson Cancer CenterCompletedLymphadenopathyUnited States
-
Hopital LariboisièreUnité de Recherches Therapeutiques - H. LariboisiereCompletedAtrial Fibrillation | Arrhythmia | Atrial FlutterFrance
-
Beijing Anzhen HospitalUnknown
-
Mayo ClinicCompletedObesity | Insulin ResistanceUnited States
-
Tongji HospitalUnknown